Sarah Cannon Research Institute at Tennessee Oncology Nashville — Nashville, Tennessee

Sarah Cannon Research Institute at Tennessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at Tennessee Oncology Nashville has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: Centessa Pharmaceuticals (UK) Limited.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at Tennessee Oncology Nashville?

Sarah Cannon Research Institute at Tennessee Oncology Nashville has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at Tennessee Oncology Nashville conducted?

Sarah Cannon Research Institute at Tennessee Oncology Nashville has 1 clinical trials on record. Their work covers Advanced Solid Tumor.

Is Sarah Cannon Research Institute at Tennessee Oncology Nashville accredited by Crixeo Health?

Sarah Cannon Research Institute at Tennessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute at Tennessee Oncology Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.